AstraZeneca's ($AZN) MedImmune has licensed a toll-like receptor (TLR) agonist from 3M ($MMM), in the hopes that intratumoral injection of the candidate will allow ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results